The Bay Area startup has designed a menu of apps related to sleep, caffeine metabolism, and other indications.
An OpenArray panel designed to simultaneously test for 17 viruses and 13 bacteria and protozoa was able to detect pathogens from human blood donor samples with an accuracy of about 95 percent.
In a recent regulatory filing, Thermo disclosed that it acquired Core Informatics for $94 million and Finesse Solutions for $220 million.
Cornell and Life Technologies sued Illumina in 2010, alleging Illumina's microarray products infringed on eight of their patents.
The Thermo Fisher subsidiary is not liable to Promega in the US for selling infringing forensic DNA kits in Europe, containing US-manufactured Taq polymerase.
The case is being framed as either upholding a strong patent regime or dealing a blow to US-based manufacturing as part of the global supply chain.
The firm sees the new panel as an important step forward in its strategy to further penetrate the molecular diagnostics market with its qPCR products.
Thermo Fisher Scientific subsidiary Life Technologies will pay Enzo $35 million for infringing on two patents pertaining to labeled nucleotides and nucleic acids.
In PNAS this week: common variants that influence viral load in HIV patients, tumor evolution patterns, and more.
Experts at Vanderbilt discussed future expansion of its PREDICT program, and provided a glimpse at how doctors have responded to genomic information in EMRs.
Gene drives might run into biological resistance, the Economist reports.
Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.
Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.
In Science this week: full CRISPR locus integration complex structure, and more.